Physician profile
Raphael K Sung
NPI 1962567206
$69,431.63
in general payments reported to CMS, 2019-2025
25 companies · $30K in 2025
The $30K reported for 2025 was more than what 92% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,385 · 2020: $1,116 · 2021: $545 · 2022: $1,333 · 2023: $4,755 · 2024: $26K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $40K · Travel and Lodging: $9,811 · Food and Beverage: $8,242 · Consulting Fee: $3,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $39,500.00 |
| Travel and Lodging | $9,811.23 |
| Food and Beverage | $8,242.24 |
| Consulting Fee | $3,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $46,156.85 | 2019-2025 | Lifevest |
| Medtronic, INC. | $5,901.85 | 2021-2025 | Linq II, Micra, Evera Mri Xt Dr Surescan |
| Zoll Respicardia, INC. | $5,740.30 | 2019-2024 | Remede System |
| Boston Scientific Corporation | $3,703.47 | 2019-2025 | Watchman Access System, Watchman Flx, Farapulse |
| Medtronic Vascular, INC. | $2,088.80 | 2019-2020 | |
| Biosense Webster, INC. | $1,900.53 | 2020-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro Catheter |
| Medical Device Business Services, INC. | $1,210.28 | 2023 | Carto 3 |
| Acutus Medical, INC. | $549.36 | 2020 | |
| Abbott Laboratories | $487.24 | 2019-2024 | Gallant, Assurity |
| Cvrx, INC. | $434.62 | 2022-2023 | Barostim Neo System |
| Atricure, INC. | $268.30 | 2022 | |
| Impulse Dynamics (USA) INC. | $182.13 | 2022-2023 | Optimizer |
| Cardiofocus, INC. | $177.98 | 2022 | |
| Biotronik INC. | $126.93 | 2019-2024 | Renamic Neo, Amvia Edge, Acticor 7 Vr-T Dx |
| Bayer Healthcare Pharmaceuticals INC. | $123.12 | 2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stereotaxis INC | $88.01 | 2020 | |
| Philips North America LLC | $67.89 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $50.96 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $45.40 | 2019 | |
| Cardiva Medical, INC. | $33.44 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Lundbeck LLC | $27.32 | 2019 | |
| Kestra Medical Technology Services, INC. | $20.42 | 2023 | Assure Wcd |
| Kowa Pharmaceuticals America, INC. | $17.73 | 2019 | |
| Pfizer INC. | $17.69 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raphael Sung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.